(Q44416932)

English

Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease

scientific article published in April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease (English)

1 reference

Europe PubMed Central

2 December 2017

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

intermittent claudication

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Sergio Mondillo

object named as

Sergio Mondillo

1

0 references

author name string

Piercarlo Ballo

2

1 reference

Europe PubMed Central

2 December 2017

Riccardo Barbati

3

1 reference

Europe PubMed Central

2 December 2017

Francesco Guerrini

4

1 reference

Europe PubMed Central

2 December 2017

Tiziana Ammaturo

5

1 reference

Europe PubMed Central

2 December 2017

Eustachio Agricola

6

1 reference

Europe PubMed Central

2 December 2017

Monica Pastore

7

1 reference

Europe PubMed Central

2 December 2017

Francesco Borrello

8

1 reference

Europe PubMed Central

2 December 2017

Mirko Belcastro

9

1 reference

Europe PubMed Central

2 December 2017

Andrea Picchi

10

1 reference

Europe PubMed Central

2 December 2017

Renato Nami

11

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

2 December 2017

American Journal of Medicine

1 reference

Europe PubMed Central

2 December 2017

114

1 reference

Europe PubMed Central

2 December 2017

359-364

1 reference

Europe PubMed Central

2 December 2017

5

1 reference

Europe PubMed Central

2 December 2017

The prevalence of peripheral arterial disease in a defined population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Randomized trial of the effects of low-dose calcium-heparin in patients with peripheral arterial disease and claudication. Italian CAP Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

European multicenter study on propionyl-L-carnitine in intermittent claudication.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

The ankle brachial index independently predicts walking velocity and walking endurance in peripheral arterial disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Mechanisms modifying atherosclerotic disease - from lipids to vascular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900010-X

7 January 2021

Identifiers

10.1016/S0002-9343(03)00010-X

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44416932&oldid=2022461741"